The effects of the controversial Alzheimer’s drug, aducanumab, were improved by using a low-dose ultrasound to better “open” the blood brain barrier, according to research led by Rockefeller Neuroscience Institute.Their study was published today in the New England Journal of Medicine. The lead author is Rockefeller’s Ali R. Rezai, MD.“The reduction in the level of […]
